These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3210265)

  • 1. Pharmacokinetic estimation for therapeutic dosage regimens (PETDR)--a software program designed to determine intravenous drug dosage regimens for veterinary applications.
    Riviere JE; Frazier DL; Tippitt WL
    J Vet Pharmacol Ther; 1988 Dec; 11(4):390-6. PubMed ID: 3210265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state dosage regimen calculations in linear pharmacokinetics.
    Iliadis A; Bruno R; Cano JP
    Int J Biomed Comput; 1986 May; 18(3-4):167-82. PubMed ID: 3755120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pocket calculator program for pharmacokinetic dosing of drugs exhibiting single compartment first-order elimination and zero-order or first-order absorption.
    Hochstrasser DF; Fleck RJ; Hull JH; Sarubbi FA
    Comput Biomed Res; 1984 Feb; 17(1):27-37. PubMed ID: 6546538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A calculator program for clinical application of the Bayesian method of predicting plasma drug levels.
    Ruffo S; Messori A; Grasela TH; Longo G; Donati-Cori G; Matucci M; Morfini M; Tendi E
    Comput Programs Biomed; 1985; 19(2-3):167-77. PubMed ID: 3928243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.
    Lin Z; Li M; Gehring R; Riviere JE
    J Pharm Sci; 2015 Jan; 104(1):233-43. PubMed ID: 25407474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal dosage regimen calculation program based on the remaining drug concentrations in plasma.
    Takada K; Yoshikawa H; Muranishi S
    Int J Biomed Comput; 1985 May; 16(3-4):267-75. PubMed ID: 3839212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calculator program to determine k and V from measured serum drug concentrations by a two point curve fitting method.
    Jones EM
    Int J Biomed Comput; 1982 Sep; 13(5):387-402. PubMed ID: 6897058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of four once-daily aminoglycoside dosing nomograms.
    Wallace AW; Jones M; Bertino JS
    Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.
    Fuster-Lluch O; Zapater-Hernández P; Gerónimo-Pardo M
    J Clin Pharmacol; 2017 Oct; 57(10):1345-1352. PubMed ID: 28419483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of fluconazole in loggerhead sea turtles (Caretta caretta) after single intravenous and subcutaneous injections, and multiple subcutaneous injections.
    Mallo KM; Harms CA; Lewbart GA; Papich MG
    J Zoo Wildl Med; 2002 Mar; 33(1):29-35. PubMed ID: 12216790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualization of drug dosage regimens.
    Platt DR
    Clin Lab Med; 1987 Jun; 7(2):289-99. PubMed ID: 3301171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goal-oriented, model-based drug regimens: setting individualized goals for each patient.
    Jelliffe R
    Ther Drug Monit; 2000 Jun; 22(3):325-9. PubMed ID: 10850402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.
    Slattery JT
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):105-10. PubMed ID: 7381689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.
    Jelliffe RW; Schumitzky A; Van Guilder M; Liu M; Hu L; Maire P; Gomis P; Barbaut X; Tahani B
    Ther Drug Monit; 1993 Oct; 15(5):380-93. PubMed ID: 8249044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of drug dosage regimens with a pharmacokinetic slide rule.
    Straughn AB; Cruze CA; Meyer MC
    Am J Hosp Pharm; 1977 Feb; 34(2):197-200. PubMed ID: 842548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Steady-state characteristics and optimal dosage regimens for Michaelis-Menten elimination drugs].
    Liu D; Li J; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):61-5. PubMed ID: 7657342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam.
    Kim MK; Capitano B; Mattoes HM; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP
    Pharmacotherapy; 2002 May; 22(5):569-77. PubMed ID: 12013355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of theophylline dosage regimens from limited serum sampling.
    Robinson JD; Boysen PG; Lupkiewicz SM; Krischer JP; Ariet M
    Drug Intell Clin Pharm; 1982 Oct; 16(10):752-8. PubMed ID: 6897223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.